| The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction F Van Der Made, J Bloemers, WE Yassem, G Kleiverda, W Everaerd, ... The journal of sexual medicine 6 (3), 777-790, 2009 | 107 | 2009 |
| Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system … S Poels, J Bloemers, K van Rooij, I Goldstein, J Gerritsen, D van Ham, ... The journal of sexual medicine 10 (3), 810-823, 2013 | 92 | 2013 |
| Toward Personalized Sexual Medicine (Part 3): Testosterone Combined with a Serotonin1A Receptor Agonist Increases Sexual Satisfaction in Women with HSDD … K van Rooij, S Poels, J Bloemers, I Goldstein, J Gerritsen, D van Ham, ... The Journal of Sexual Medicine 10 (3), 824-837, 2013 | 74 | 2013 |
| Toward personalized sexual medicine (part 1): integrating the “dual control model” into differential drug treatments for hypoactive sexual desire disorder and female sexual … J Bloemers, K van Rooij, S Poels, I Goldstein, W Everaerd, ... The Journal of Sexual Medicine 10 (3), 791-809, 2013 | 70 | 2013 |
| The clitoral photoplethysmograph: A new way of assessing genital arousal in women J Gerritsen, F Van Der Made, J Bloemers, D Van Ham, G Kleiverda, ... The journal of sexual medicine 6 (6), 1678-1687, 2009 | 62 | 2009 |
| Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual … F Van Der Made, J Bloemers, D Van Ham, WE Yassem, G Kleiverda, ... The journal of sexual medicine 6 (2), 429-439, 2009 | 51 | 2009 |
| ANATOMY/PHYSIOLOGY: Induction of Sexual Arousal in Women Under Conditions of Institutional and Ambulatory Laboratory Circumstances: A Comparative Study J Bloemers, J Gerritsen, R Bults, H Koppeschaar, W Everaerd, B Olivier, ... The journal of sexual medicine 7 (3), 1160-1176, 2010 | 50 | 2010 |
| Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials A Tuiten, K van Rooij, J Bloemers, C Eisenegger, J van Honk, R Kessels, ... The journal of sexual medicine 15 (2), 201-216, 2018 | 44 | 2018 |
| Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women K van Rooij, J Bloemers, L de Leede, I Goldstein, E Lentjes, ... Psychoneuroendocrinology 37 (6), 773-781, 2012 | 36 | 2012 |
| Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin 1A receptor agonist in women with SSRI-induced sexual dysfunction. A … K van Rooij, S Poels, P Worst, J Bloemers, H Koppeschaar, A Goldstein, ... European journal of pharmacology 753, 246-251, 2015 | 31 | 2015 |
| Reduced gray matter volume and increased white matter fractional anisotropy in women with hypoactive sexual desire disorder J Bloemers, HS Scholte, K van Rooij, I Goldstein, J Gerritsen, B Olivier, ... The Journal of Sexual Medicine 11 (3), 753-767, 2014 | 31 | 2014 |
| Two novel combined drug treatments for women with hypoactive sexual desire disorder S Poels, J Bloemers, K van Rooij, H Koppeschaar, B Olivier, A Tuiten Pharmacology Biochemistry and Behavior 121, 71-79, 2014 | 28 | 2014 |
| Pharmacokinetics of a prototype formulation of sublingual testosterone and a buspirone tablet, versus an advanced combination tablet of testosterone and buspirone in healthy … K Van Rooij, L De Leede, HW Frijlink, J Bloemers, S Poels, ... Drugs in R&D 14, 125-132, 2014 | 17 | 2014 |
| Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction JJA Tuiten, JMM Bloemers US Patent 9,333,203, 2016 | 16 | 2016 |
| Single dose sublingual testosterone and oral sildenafil vs. a dual route/dual release fixed dose combination tablet: a pharmacokinetic comparison J Bloemers, K van Rooij, L de Leede, HW Frijlink, HPF Koppeschaar, ... British journal of clinical pharmacology 81 (6), 1091-1102, 2016 | 15 | 2016 |
| Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction JJA Tuiten, JMM Bloemers, RPJ De Lange US Patent 8,575,139, 2013 | 14 | 2013 |
| Methods for assessing and controlling placebo effects R Kessels, R Mozer, J Bloemers Statistical Methods in Medical Research 28 (4), 1141-1156, 2019 | 13 | 2019 |
| Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: a double-blind, randomized, placebo-controlled cross-over trial A Tuiten, F Michiels, KBE Böcker, D Höhle, J van Honk, RPJ de Lange, ... Women's Health 14, 1745506518788970, 2018 | 11 | 2018 |
| Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction JJA Tuiten, JMM Bloemers, RPJ De Lange US Patent 8,653,051, 2014 | 11 | 2014 |
| Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction JJA Tuiten, JMM Bloemers, RPJ De Lange US Patent 8,648,060, 2014 | 11 | 2014 |
Adriaan TuitenDr. A. Tuiten, CEO, Emotional Brain BV AlmereGeverifieerd e-mailadres voor emotionalbrain.nl
